Clinical trial

A Study to Evaluate the Pharmacokinetic Interaction and the Safety of AD-236A and AD-236B

NCT07730567

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2026-07-29

PhasePHASE1

Study timeline

Study start (estimated)2026-07-29Date precision: day

Registry last updated2026-07-28

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Hyperlipidemiaunresolved

Diabete Type 2unresolved

Interventions

Treatment A(AD-236A)DRUG

Treatment B(AD-236B)DRUG

Treatment C(AD-236A+AD-236B)DRUG

Sponsors & collaborators

Addpharma Inc.lead sponsor

Mapped research locations

SeoulSouth Korea1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07730567 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.